FilingIndex
10-KThe Record

ArriVent BioPharma, Inc. files 10-K

Filed Mar 28, 2024 · 2y ago · Accession 0001558370-24-004280

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
AVBP
CIK
1868279
Form type
10-K
Filing date
Mar 28, 2024
Report date
Dec 31, 2023
Document
tmb-20231231x10k.htm
Size
4.2 MB